Occudo Quantitative Strategies LP Co Diagnostics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.76 - $6.29 $120,440 - $201,481	32,032 New	32,032 $180,000
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $64,394 - $123,027	-12,802 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $643,242 - $821,480	-79,217 Reduced 86.09%	12,802 $114,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $362,398 - $551,349	48,449 Added 111.2%	92,019 $895,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $311,961 - $416,529	43,570 New	43,570 $359,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.